English

• 

• 1. [1] I. Visintin, Z.D. Feng, G. Longton, et al., Diagnostic markers for early detection of ovarian cancer, Clin. Cancer Res. 14 (2008) 1065-1072.[1] I. Visintin, Z.D. Feng, G. Longton, et al., Diagnostic markers for early detection of ovarian cancer, Clin. Cancer Res. 14 (2008) 1065-1072.

  2. [2] E.M. Posadas, F. Simpkins, L.A. Liotta, C. MacDonald, E.C. Kohn, Proteomic analysis for the early detection and rational treatment of cancer - realistic hope? Ann. Oncol. 16 (2005) 16-22.[2] E.M. Posadas, F. Simpkins, L.A. Liotta, C. MacDonald, E.C. Kohn, Proteomic analysis for the early detection and rational treatment of cancer - realistic hope? Ann. Oncol. 16 (2005) 16-22.

  3. [3] J.J. Ott, A. Ullrich, A.B. Miller, The importance of early symptom recognition in the context of early detection and cancer survival, Eur. J. Cancer 45 (2009) 2743-2748.[3] J.J. Ott, A. Ullrich, A.B. Miller, The importance of early symptom recognition in the context of early detection and cancer survival, Eur. J. Cancer 45 (2009) 2743-2748.

  4. [4] R. Gennari, U. Veronesi, C. Andreoli, et al., Early detection of cancer: ideas for a debate, Crit. Rev. Oncol./Hematol. 61 (2007) 97-103.[4] R. Gennari, U. Veronesi, C. Andreoli, et al., Early detection of cancer: ideas for a debate, Crit. Rev. Oncol./Hematol. 61 (2007) 97-103.

  5. [5] N.S. Jain, U.H.N. Dü rr, A. Ramamoorthy, Bioanalytical methods for metabolomic profiling: detection of head and neck cancer, including oral cancer, Chin, Chem. Lett. 26 (2015) 407-415.[5] N.S. Jain, U.H.N. Dü rr, A. Ramamoorthy, Bioanalytical methods for metabolomic profiling: detection of head and neck cancer, including oral cancer, Chin, Chem. Lett. 26 (2015) 407-415.

  6. [6] Y.W. Kong, D. Ferland-McCollough, T.J. Jackson, M. Bushell, microRNAs in cancer management, Lancet Oncol. 13 (2012) e249-e258.[6] Y.W. Kong, D. Ferland-McCollough, T.J. Jackson, M. Bushell, microRNAs in cancer management, Lancet Oncol. 13 (2012) e249-e258.

  7. [7] J.M. Yi, A.A. Guzzetta, V.J. Bailey, et al., Novel methylation biomarker panel for the early detection of pancreatic cancer, Clin. Cancer Res. 19 (2013) 6544-6555.[7] J.M. Yi, A.A. Guzzetta, V.J. Bailey, et al., Novel methylation biomarker panel for the early detection of pancreatic cancer, Clin. Cancer Res. 19 (2013) 6544-6555.

  8. [8] C. Chapman, A. Murray, J. Chakrabarti, et al., Autoantibodies in breast cancer: their use as an aid to early diagnosis, Ann. Oncol. 18 (2007) 868-873.[8] C. Chapman, A. Murray, J. Chakrabarti, et al., Autoantibodies in breast cancer: their use as an aid to early diagnosis, Ann. Oncol. 18 (2007) 868-873.

  9. [9] D.H. Chen, C.Q. Zhao, J. Ye, et al., In situ biosynthesis of fluorescent platinumnanoclusters: towards self-bio-imaging guided cancer theranostics, ACS Appl. Mater. Interfaces (2015), http://dx.doi.org/10.1021/acsami.5b05805.[9] D.H. Chen, C.Q. Zhao, J. Ye, et al., In situ biosynthesis of fluorescent platinumnanoclusters: towards self-bio-imaging guided cancer theranostics, ACS Appl. Mater. Interfaces (2015), http://dx.doi.org/10.1021/acsami.5b05805.

  10. [10] A.H. Fu, W.W. Gu, C. Larabell, A.P. Alivisatos, Semiconductor nanocrystals for biological imaging, Curr. Opin. Neurobiol. 15 (2005) 568-575.[10] A.H. Fu, W.W. Gu, C. Larabell, A.P. Alivisatos, Semiconductor nanocrystals for biological imaging, Curr. Opin. Neurobiol. 15 (2005) 568-575.

  11. [11] X.S. Tang, E.S.G. Choo, L. Li, J. Ding, J.M. Xue, Synthesis of Zno nanoparticles with tunable emission colors and their cell labeling applications, Chem. Mater. 22 (2010) 3383-3388.[11] X.S. Tang, E.S.G. Choo, L. Li, J. Ding, J.M. Xue, Synthesis of Zno nanoparticles with tunable emission colors and their cell labeling applications, Chem. Mater. 22 (2010) 3383-3388.

  12. [12] J. Safaei-Ghomi, M.A. Ghasemzadeh, Zinc oxide nanoparticles: a highly efficient and readily recyclable catalyst for the synthesis of xanthenes, Chin. Chem. Lett. 23 (2012) 1225-1229.[12] J. Safaei-Ghomi, M.A. Ghasemzadeh, Zinc oxide nanoparticles: a highly efficient and readily recyclable catalyst for the synthesis of xanthenes, Chin. Chem. Lett. 23 (2012) 1225-1229.

  13. [13] H.B. Ren, B.Y. Wu, J.T. Chen, X.P. Yan, Silica-coated S^2- -enriched manganesedoped ZnS Quantum Dots as a photoluminescence probe for imaging intracellular Zn²⁺ ions, Anal. Chem. 83 (2011) 8239-8244.[13] H.B. Ren, B.Y. Wu, J.T. Chen, X.P. Yan, Silica-coated S^2- -enriched manganesedoped ZnS Quantum Dots as a photoluminescence probe for imaging intracellular Zn²⁺ ions, Anal. Chem. 83 (2011) 8239-8244.

  14. [14] J.L. Wang, G. Zhang, Q.W. Li, et al., In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters, Sci. Rep. 3 (2013) 1157.[14] J.L. Wang, G. Zhang, Q.W. Li, et al., In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters, Sci. Rep. 3 (2013) 1157.

  15. [15] S.P. Gao, D.H. Chen, Q.W. Li, et al., Near-infrared fluorescence imaging of cancer cells and tumors through specific biosynthesis of silver nanoclusters, Sci. Rep. 4 (2014) 4384.[15] S.P. Gao, D.H. Chen, Q.W. Li, et al., Near-infrared fluorescence imaging of cancer cells and tumors through specific biosynthesis of silver nanoclusters, Sci. Rep. 4 (2014) 4384.

  16. [16] M.L. Circu, T.Y. Aw, Reactive oxygen species, cellular redox systems, and apoptosis, Free Radic. Biol. Med. 48 (2010) 749-762.[16] M.L. Circu, T.Y. Aw, Reactive oxygen species, cellular redox systems, and apoptosis, Free Radic. Biol. Med. 48 (2010) 749-762.

  17. [17] D. Trachootham, J. Alexandre, P. Huang, Targeting cancer cells by Ros-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8 (2009) 579-591.[17] D. Trachootham, J. Alexandre, P. Huang, Targeting cancer cells by Ros-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8 (2009) 579-591.

•